RadNet, Inc. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- RadNet, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2020-12-31 was $0.00.
- RadNet, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
- RadNet, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2020-06-30 was $33.01M.
- RadNet, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2019-09-30 was $1.50M.
- RadNet, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2023 was $11.47M.
- RadNet, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2020 was $33.01M.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2023-12-31 | $11.47M 10-K · filed 2024-02-29 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $33.01M 10-K · filed 2023-03-01 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | |
| 2020-06-30 | $33.01M 10-Q · filed 2021-08-09 | |
| 2019-09-30 | $1.50M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | |
| 2019-03-31 | $6.00M 10-Q · filed 2020-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |